Drug-induced dyslipidemia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hyperlipidemia may be caused or exacerbated by many conditions including pharmacotherapy. A wide variety of medications can cause adverse effects on lipid metabolism leading to dyslipidemia. These include antihypertensives such as thiazide diuretics and nonspecific beta-adrenergic blockers, various steroid hormones including glucocorticoids, estrogens, androgens, and their related compounds, immunosuppressive medications, antineoplastic agents, atypical antipsychotics, HIV-1 protease inhibitors, antiepileptics, and other miscellaneous drugs. The effect of some medications is mild and of little clinical significance, while others can cause severe hyperlipidemia and acute complications such as pancreatitis. This chapter focuses on some of the common medications causing dyslipidemia, the magnitude of their effects, and its mechanisms, and management. Awareness about drug-induced dyslipidemia is essential for providing optimal care to patients with lipid disorders.

Original languageEnglish (US)
Title of host publicationDyslipidemias
Subtitle of host publicationPathophysiology, Evaluation and Management
PublisherHumana Press Inc.
Pages267-286
Number of pages20
ISBN (Electronic)9781607614241
ISBN (Print)9781607614234
DOIs
StatePublished - Jan 1 2015

Fingerprint

Dyslipidemias
Hyperlipidemias
Pharmaceutical Preparations
HIV Protease Inhibitors
Sodium Chloride Symporter Inhibitors
Adrenergic beta-Antagonists
Immunosuppressive Agents
Lipid Metabolism
Pancreatitis
Antineoplastic Agents
Anticonvulsants
Antihypertensive Agents
Glucocorticoids
Antipsychotic Agents
Androgens
Patient Care
Estrogens
Steroids
Hormones
Lipids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Simha, V. (2015). Drug-induced dyslipidemia. In Dyslipidemias: Pathophysiology, Evaluation and Management (pp. 267-286). Humana Press Inc.. https://doi.org/10.1007/978-1-60761-424-1-15

Drug-induced dyslipidemia. / Simha, Vinaya.

Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., 2015. p. 267-286.

Research output: Chapter in Book/Report/Conference proceedingChapter

Simha, V 2015, Drug-induced dyslipidemia. in Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., pp. 267-286. https://doi.org/10.1007/978-1-60761-424-1-15
Simha V. Drug-induced dyslipidemia. In Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc. 2015. p. 267-286 https://doi.org/10.1007/978-1-60761-424-1-15
Simha, Vinaya. / Drug-induced dyslipidemia. Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., 2015. pp. 267-286
@inbook{dbb13425af994f44a6be82da5179217e,
title = "Drug-induced dyslipidemia",
abstract = "Hyperlipidemia may be caused or exacerbated by many conditions including pharmacotherapy. A wide variety of medications can cause adverse effects on lipid metabolism leading to dyslipidemia. These include antihypertensives such as thiazide diuretics and nonspecific beta-adrenergic blockers, various steroid hormones including glucocorticoids, estrogens, androgens, and their related compounds, immunosuppressive medications, antineoplastic agents, atypical antipsychotics, HIV-1 protease inhibitors, antiepileptics, and other miscellaneous drugs. The effect of some medications is mild and of little clinical significance, while others can cause severe hyperlipidemia and acute complications such as pancreatitis. This chapter focuses on some of the common medications causing dyslipidemia, the magnitude of their effects, and its mechanisms, and management. Awareness about drug-induced dyslipidemia is essential for providing optimal care to patients with lipid disorders.",
author = "Vinaya Simha",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-60761-424-1-15",
language = "English (US)",
isbn = "9781607614234",
pages = "267--286",
booktitle = "Dyslipidemias",
publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Drug-induced dyslipidemia

AU - Simha, Vinaya

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hyperlipidemia may be caused or exacerbated by many conditions including pharmacotherapy. A wide variety of medications can cause adverse effects on lipid metabolism leading to dyslipidemia. These include antihypertensives such as thiazide diuretics and nonspecific beta-adrenergic blockers, various steroid hormones including glucocorticoids, estrogens, androgens, and their related compounds, immunosuppressive medications, antineoplastic agents, atypical antipsychotics, HIV-1 protease inhibitors, antiepileptics, and other miscellaneous drugs. The effect of some medications is mild and of little clinical significance, while others can cause severe hyperlipidemia and acute complications such as pancreatitis. This chapter focuses on some of the common medications causing dyslipidemia, the magnitude of their effects, and its mechanisms, and management. Awareness about drug-induced dyslipidemia is essential for providing optimal care to patients with lipid disorders.

AB - Hyperlipidemia may be caused or exacerbated by many conditions including pharmacotherapy. A wide variety of medications can cause adverse effects on lipid metabolism leading to dyslipidemia. These include antihypertensives such as thiazide diuretics and nonspecific beta-adrenergic blockers, various steroid hormones including glucocorticoids, estrogens, androgens, and their related compounds, immunosuppressive medications, antineoplastic agents, atypical antipsychotics, HIV-1 protease inhibitors, antiepileptics, and other miscellaneous drugs. The effect of some medications is mild and of little clinical significance, while others can cause severe hyperlipidemia and acute complications such as pancreatitis. This chapter focuses on some of the common medications causing dyslipidemia, the magnitude of their effects, and its mechanisms, and management. Awareness about drug-induced dyslipidemia is essential for providing optimal care to patients with lipid disorders.

UR - http://www.scopus.com/inward/record.url?scp=84956764713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956764713&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-424-1-15

DO - 10.1007/978-1-60761-424-1-15

M3 - Chapter

AN - SCOPUS:84956764713

SN - 9781607614234

SP - 267

EP - 286

BT - Dyslipidemias

PB - Humana Press Inc.

ER -